Researchers at the University of Surrey have identified a protein that acts as a control switch, preventing Mycobacterium tuberculosis from accessing the energy sources it needs to survive. The discovery points to a specific vulnerability in the bacterium that could be targeted by new tuberculosis (TB) treatments. The work is published in the journal EMBO Reports.